Two proteins present in the blood and brains of patients with Huntington’s disease may be used as biomarkers to…
Diogo Pinto
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Diogo Pinto
Active Biotech. has regained global development and commercialization rights of laquinimod, an investigational immunotherapy for neurodegenerative diseases, including Huntington’s…
An investigational compound called VU0409551Â could reverse memory deficiencies and improve learning, according to the results of a mouse study…
CHDI Foundation has teamed up with PTC Therapeutics to try to advance PTC’s work on small-molecule compounds that can reduce…